loading

Indaptus Therapeutics Inc Azioni (INDP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
45.53%
4.5726
3.1421 4.1089 3.9432 4.1796
Operating Income/Loss
45.53%
-4.5726
-3.1421 -4.1089 -3.9432 -4.1796
Nonoperating Income/Loss
45.04%
0.0401
0.073 0.0936 0.1366 0.1769
Income/Loss From Continuing Operations Before Tax
47.68%
-4.5324
-3.069 -4.0153 -3.8067 -4.0003
Income/Loss From Continuing Operations After Tax
47.68%
-4.5324
-3.069 -4.0153 -3.8067 -4.0028
Net Income/Loss
47.68%
-4.5324
-3.069 -4.0153 -3.8067 -4.0028
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
48.28%
14.10
9.5104 8.5439 8.4424 -
Diluted Average Shares
48.28%
14.10
9.5104 8.5439 8.4424 -
Basic Earnings Per Share
0.00%
-0.32
-0.32 -0.47 -0.45 -0.47
Diluted Earnings Per Share
0.00%
-0.32
-0.32 -0.47 -0.45 -0.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.36
price down icon 0.93%
$83.10
price down icon 3.56%
$27.82
price down icon 2.76%
$96.74
price down icon 7.26%
$145.93
price up icon 0.10%
biotechnology ONC
$324.34
price down icon 3.38%
Capitalizzazione:     |  Volume (24 ore):